Glutathione-dependent reduction of arsenate in human erythrocytes - A process independent of purine nucleoside phosphorylase

Toxicological Sciences

Volumn 82, Issue 2, 2004, Pages 419-428

  Németi, Balázs ^a   Gregus, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arsenate; Arsenite; Erythrocyte; Glutathione; Purine nucleoside phosphorylase; Reduction

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; ARSENIC ACID; DITHIOTHREITOL; ENOLASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PURINE NUCLEOSIDE PHOSPHORYLASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ERYTHROCYTE; GLUCOSE METABOLISM; GLYCOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; SPECTROFLUOROMETRY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ARSENATES; ARSENITE TRANSPORTING ATPASES; BLOOD GLUCOSE; DITHIOTHREITOL; ERYTHROCYTES; FERRICYANIDES; GLUCOSE OXIDASE; GLUTATHIONE; HUMANS; INOSINE; ION PUMPS; MULTIENZYME COMPLEXES; NADP; OXIDATION-REDUCTION; PURINE-NUCLEOSIDE PHOSPHORYLASE; PYRIMIDINONES; PYRROLES; PYRUVIC ACID; SPECTROPHOTOMETRY, ATOMIC;

EID: 10044259621     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh301     Document Type: Article

References (52)

1. Afolayan, A., and Luzzatto, L. (1971). Genetic variants of human erythrocyte glucose-6-phosphate dehydrogenase. I. Regulation of activity by oxidized and reduced nicotinamide-adenine dinucleotide phosphate. Biochemistry 10, 415-419.
2. Bertolero, F., Pozzi, G., Sabbioni, E., and Saffiotti, U. (1987). Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants cytotoxicity and morphological transformation. Carcinogenesis 8, 803-808.
3. Chiodi, H., and Mohler, J. G. (1987). Nonautocatalytic methemoglobin formation by sodium nitrite under aerobic and anaerobic conditions. Environ. Res. 44, 45-55.
4. Csanaky, I., and Gregus, Z. (2001). Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicol. Sci. 63, 29-36.
5. Csanaky, I., and Gregus, Z. (2004). Role of glutathione in reduction of arsenate and of γ-glutamyltranspeptidase in disposition of arsenite in rats. Toxicology (in press).
6. Csanaky, I., Németi, B., and Gregus, Z. (2003). Dose-dependent biotransformation of arsenite in rats - not S adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183, 77-91.
7. Delnomdedieu, M., Basti, M. M., Otvos, J. D., and Thomas, D. J. (1994). Reduction and binding of arsenate and dimethylarsinate by glutathione: A nuclear magnetic resonance study. Chem. Biol. Interact. 90, 139-155.
8. Dixon, H. B. F. (1997). The biochemical action of arsonic acids, especially as phosphate analogues. Adv. Inorg. Chem. 44, 191-227.
9. Fuhr, B. J., and Rabenstein, D. L. (1973). Nuclear magnetic resonance studies of the solution chemistry of metal complexes. IX. The binding of cadmium, zinc, lead, and mercury by glutathione. J. Am. Chem. Soc. 95, 6944-6950.
10. Ginsburg, J. M., and Lotspeich, W. D. (1963). Interrelations of arsenate and phosphate transport in the dog kidney. Am. J. Physiol. 205, 707-714.
11. Goering, P. L., Aposhian, H. V., Mass, M. J., Cebrián, M., Beck, B. D., and Waalkes, M. P. (1999). The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol. Sci. 49, 5-14.
12. Gomez-Ariza, J. L., Sánchez-Rodas, D., Beltran, R., Corns, W., and Stockwel, P. (1998). Evaluation of atomic fluorescence spectrometry as a sensitive detection technique for arsenic speciation. Appl. Organometal. Chem. 12, 439-447.
13. Gregus, Z., Gyurasics, Á., and Csanaky, I. (2000). Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56, 18-25.
14. Gregus, Z., and Németi, B. (2002). Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70, 13-19.
15. Gyurasics, Á., Varga, F., and Gregus, Z. (1991). Glutathione-dependent biliary excretion of arsenic. Biochem. Pharmacol. 42, 465-468.
16. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry 37, 7578-7588.
17. Hindmarsh, J. T. (2000). Arsenic, its clinical and environmental significance. J. Trace Elem. Exp. Med. 13, 165-172.
18. Hughes, M. F. (2002). Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133, 1-16.
19. Inoue, K., Ohbora, Y., and Yamasawa, K. (1978). Metabolism of acetaldehyde by human erythrocytes. Life Sci. 23, 179-183.
20. Kalckar, H. M. (1947). Differential spectrophotometry of purine compounds by means of specific enzymes: I. Determination of hydroxypurines. J. Biol. Chem. 167, 429-443.
21. Kenney, L. J., and Kaplan, J. H. (1988). Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. J. Biol. Chem. 263, 7954-7960.
22. Knowles, F. C., and Benson, A. A. (1983). The biochemistry of arsenic. Trends Biochem. Sci. 8, 178-180.
23. Kosower, N. S., Vanderhoff, G. A., and London, I. M. (1967). The regeneration of reduced glutathione in normal and glucose-6-phosphate dehydrogenase deficient human red blood cells. Blood 29, 313-319.
24. Kurata, M., Suzuki, M., and Agar, N. S. (2000). Glutathione regeneration in mammalian erythrocytes. Comp. Haematol. Intern. 10, 59-67.
25. Ludwig, E., and Eyer, P. (1995a). Oxidation versus addition reactions of glutathione during the interactions with quinoid thioethers of 4-(dimethylamino) phenol. Chem. Res. Toxicol. 8, 302-309.
26. Ludwig, E., and Eyer, P. (1995b). Reactivity of glutathione adducts of 4-(dimethylamino)phenol. Formation of a highly reactive cyclization product. Chem. Res. Toxicol. 8, 310-315.
27. May, J. M. (1999). Is ascorbic acid an antioxidant for the plasma membrane? FASEB J. 13, 995-1006.
28. May, J. M., Qu, Z., and Cobb, C. E. (2004). Reduction and uptake of methylene blue by human erythrocytes. Am. J. Physiol. Cell Physiol. 286, C1390-C1398.
29. May, J. M., Qu, Z., and Morrow, J. D. (2001). Mechanisms of ascorbic acid recycling in human erythrocytes. Biochim. Biophys. Acta 1528, 159-166.
30. Metz, E. N., Balcerzak, S. P., and Sagone, A. L., Jr. (1976). Mechanisms of methylene blue stimulation of the hexose monophosphate shunt in erythrocytes. J. Clin. Invest. 58, 797-802.
31. 31P NMR. Biochem. J. 342, 567-580.
32. Murakami, K., and Mawatari, S. (2003). Oxidation of hemoglobin to methemoglobin in intact erythrocyte by a hydroperoxide induces formation of glutathionyl hemoglobin and binding of α -hemoglobin to membrane. Arch. Biochem. Biophys. 417, 244-250.
33. Nelson, D. L., and Cox, M. M. (2000). In Lehninger Principles of Biochemistry, 3rd ed., p. 542. Worth Publishers, New York.
34. Németi, B., Csanaky, I., and Gregus, Z. (2003). Arsenate reduction in human erythrocytes and rats - Testing the role of purine nucleoside phosphorylase. Toxicol. Sci. 74, 22-31.
35. Németi, B., and Gregus, Z. (2002a). Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol. Appl. Pharmacol. 182, 208-218.
36. Németi, B., and Gregus, Z. (2002b). Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70, 4-12.
37. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol., 14, 651-656.
38. Plummer, J. L., Smith, B. R., Sies, H., and Bend, J.R. (1981). Chemical depletion of glutathione in vivo. Methods Enzymol. 77, 50-59.
39. Radabaugh, T. R., and Aposhian, H. V. (2000). Enzymatic reduction of arsenic compounds in mammalian systems: Reduction of arsenate to arsenite by human liver arsenate reductase. Chem. Res. Toxicol. 13, 26-30.
40. Radabaugh, T. R., Sampayo-Reyes, A., Zakharyan, R. A., and Aposhian, H. V. (2002). Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15, 692-698.
41. Rossman, T. G. (2003). Mechanism of arsenic carcinogenesis: An integrated approach. Mutat. Res. 533, 37-65.
42. Schipfer, W., Neophytou, B., Trobisch, R., Groiss, O., and Goldenberg, H. (1985). Reduction of extracellular potassium ferricyanide by transmembrane NADH:(acceptor) oxidoreductase of human erythrocytes. Int. J. Biochem. 17, 819-823.
43. Thomas, D. J., Styblo, M., and Lin, S. (2001). The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176, 127-144.
44. Tilton, W. M., Seaman, C., Carriero, D., and Piomelli, S. (1991). Regulation of glycolysis in the erythrocyte: Role of the lactate/pyruvate and NAD/NADH ratios. J. Lab. Clin. Med. 118, 146-152.
45. Trinder, P. (1969). Determination of blood glucose using 4-amino phenazone as oxygen acceptor. J. Clin. Pathol. 22, 246.
46. Vahter, M. (2002). Mechanisms of arsenic biotransformation. Toxicology 181-182, 211-217.
47. Wang, T., and Himoe, A. (1974). Kinetics of the rabbit muscle enolase-catalyzed dehydration of 2-phosphoglycerate. Fluoride and phosphate inhibition. J. Biol. Chem. 249, 3895-3902.
48. Warburg, O., and Christian, W. (1941-1942). Isolation and crystallization of the glycolytic enzyme enolase (in German). Biochemische Zeitschrift 310, 385-421.
49. Washburn, M. P., and Wells, W. W. (1999). Identification of the dehydroascorbic acid reductase and thioltransferase (glutaredoxin) activities of bovine erythrocyte glutathione peroxidase. Biochem. Biophys. Res. Commun. 257, 567-571.
50. Wells, W. W., Xu, D. P., Yang, Y., and Rocque, P. A. (1990). Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J. Biol. Chem. 265, 15361-15364.
51. Xu, D. P., Washburn, M. P., Sun, G. P., and Wells, W. W. (1996). Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes. Biochem. Biophys. Res. Commun. 221, 117-121.
52. Zhang, Y., Konig, I., and Schirmer, R. H. (1988). Glutathione reductase-deficient erythrocytes as host cells of malarial parasites. Biochem. Pharmacol. 37, 861-865.